|
On The Fly
|
The major averages closed… ShowHide Related Items >><< - 04/16/21
- State Street raises FY fee revenue view to up 2.5%-4%
- 04/16/21
- State Street sees NII $460M-$465M per quarter from here in 2021
- 04/16/21
- State Street sees Q2 expenses up around 2.5% y/y
- 04/16/21
- State Street sees fee revenues up 2%-3% y/y in Q2
- $134.31 /
-14.09 (-9.49%) - 04/16/21
- Splunk slides 7% after Chief Technology Officer resigns
- 04/14/21
- Carahsoft agreement for Splunk solutions designated CETA by DoD
- 04/13/21
- Splunk CEO sells 15.5K shares of common stock
- 04/05/21
- Splunk appoints Teresa Carlson as Chief Growth Officer
- $167.43 /
+13.57 (+8.82%) - 04/16/21
- PPG rises 10.3%
- 04/16/21
- PPG rises 11.1%
- 04/16/21
- PPG rises 10.4%
- 04/16/21
- PPG says expects to complete the acquisitions of Tikkurila, Worwag during Q2
- 04/16/21
- Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial
- 04/13/21
- Pfizer can deliver 10% more vaccine doses to U.S. by end of May, says CEO
- 04/16/21
- Morgan Stanley says 'very active' in recruiting advisors
- 04/16/21
- Morgan Stanley expects net interest income to grow from current levels
- 04/16/21
- Morgan Stanley says investment banking pipelines 'healthy across products'
- 04/16/21
- Morgan Stanley says Archegos exit 'money well spent'
- $170.77 /
+10.95 (+6.85%) - 04/16/21
- Moderna cuts April vaccine shipment to Canada to 650,000 from 1.2M
- 04/14/21
- Moderna says COVID-19 vaccine seen 90% effective against all cases at six months
- 04/14/21
- Moderna says 14 different mRNA vaccine candidates entered into trials to date
LSCC Lattice Semiconductor - 04/15/21
- Lattice Semiconductor to replace PTC in S&P 400 at open on 4/20
- 02/23/21
- Lattice Semiconductor announces $60M stock buyback
- 12/15/20
- Everspin Technologies CEO Kevin Conley to step down
- 12/08/20
- Lattice Semiconductor launches 2nd generation security solution FPGAA
- 04/16/21
- J&J sees no 'causal relationship' between Covid vaccine and blood clots
- 04/16/21
- U.S. exceeds 200M COVID-19 vaccine doses administered
- 04/15/21
- Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors
- 04/15/21
- Merck to discontinue development of MRK-7110 in COVID-19 treatment
- 02/08/21
- Editas Medicine appoints James Mullen as CEO
- 01/11/21
- Editas Medicine Chief Scientific Officer Charles Albright, Ph.D to step down
- 01/11/21
- Editas Medicine says FDA clears initiation of EDIT-301 clinical trial
- 12/21/20
- Editas leads gene editing stocks higher with 46% rally to $95.42
- 04/16/21
- Citizens Financial CEO says 'confident' in outlook for balance of year
- 04/16/21
- Citizens Financial reports Q1 net interest margin 2.76% vs. 3.10% a year ago
- 01/27/21
- Citizens announces consumer financing partnership with BJ's Wholesale Club
- 01/20/21
- Citizens Financial sees high single digit decrease in FY21 NIM
- 04/15/21
- Congress to host big bank CEOs for hearings the week of May 24
- 04/15/21
- Citi reports March charge-offs 2.49% vs. 2.76% last month
- 04/15/21
- Citi has already started process for retail banking exits
- 04/15/21
- Citi sees 'a lot of upside' in Citibanamex unit
- 04/14/21
- BNY Mellon chosen as transfer agent of Charles Schwab Investment Management
- 03/22/21
- AFL-CIO teams with Wilmington Trust, BNY Mellon on retirement plan options
- 02/16/21
- Amundi US appoints BNY Mellon as fund service provider
- 02/11/21
- BNY Mellon announces formation of new digital assets unit
- 04/14/21
- Boeing forecasts 'sufficient capital' for aircraft financing sector
- 04/13/21
- Bell Boeing awarded $143.2M Navy delivery order for Osprey components
- 04/13/21
- Boeing reports 196 gross commercial airplane orders in March
- 04/13/21
- Boeing announces 77 commercial airplane deliveries in Q1
- 04/14/21
- Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine
- 04/14/21
- AstraZeneca's Tagrisso approved in China in early lung cancer
- 04/12/21
- AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint
- 04/16/21
- AstraZeneca reports U.S. clearance of proposed acquisition of Alexion
- 03/26/21
- Arcutis Biotherapeutics announces updates to its executive team
- 03/16/21
- AstraZeneca withdraws FTC notification on Alexion deal, plans to refile
- 02/22/21
- Arcturus Therapeutics acquires exclusive license from Alexion
- 04/16/21
- Alcoa rises 8.1%
- 04/15/21
- Alcoa jumps 2% to $33.50 after Q1 earnings beat
- 04/15/21
- Alcoa reports Q1 adjusted EBITDA $521M, up 44% from Q4
- 04/15/21
- Alcoa expecting strong 2021 on continued economic recovery
- 04/16/21 Wells Fargo
- Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
- 04/09/21 JMP Securities
- Goldman Sachs price target raised to $400 from $338 at JMP Securities
- 04/07/21 Barclays
- Morgan Stanley price target raised to $98 from $95 at Barclays
- 04/01/21 Deutsche Bank
- Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
- 04/09/21 Deutsche Bank
- BNY Mellon price target raised to $54 from $50 at Deutsche Bank
- 04/07/21 Barclays
- BNY Mellon price target raised to $57 from $55 at Barclays
- 03/26/21 JPMorgan
- JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
- 03/24/21
- Fly Intel: Top five analyst upgrades
- 04/09/21 Jefferies
- Citizens Financial price target raised to $47 from $42 at Jefferies
- 04/07/21 Barclays
- Citizens Financial price target raised to $54 from $49 at Barclays
- 04/01/21 Deutsche Bank
- Citizens Financial price target raised to $50 from $44 at Deutsche Bank
- 03/30/21 Stephens
- Citizens Financial price target raised to $54 from $45 at Stephens
- 04/09/21 Deutsche Bank
- State Street price target raised to $100 from $97 at Deutsche Bank
- 04/07/21 Barclays
- State Street price target raised to $104 from $99 at Barclays
- 04/01/21 Wells Fargo
- State Street price target raised to $90 from $83 at Wells Fargo
- 04/01/21 Morgan Stanley
- State Street price target raised to $103 from $102 at Morgan Stanley
- 04/13/21 Morgan Stanley
- Citi price target raised to $89 from $81 at Morgan Stanley
- 04/09/21 Jefferies
- Citi price target raised to $85 from $75 at Jefferies
- 04/07/21 Barclays
- Citi price target raised to $84 from $77 at Barclays
- 04/05/21 Cowen
- Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
- 03/23/21
- Fly Intel: Top five analyst downgrades
- 03/23/21 SVB Leerink
- SVB Leerink moving to sidelines on Alexion, five others on industry concerns
- 03/23/21 SVB Leerink
- Alexion downgraded to Market Perform from Outperform at SVB Leerink
- 02/04/21 Piper Sandler
- Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/12/21
- Fly Intel: Top five analyst downgrades
- 04/12/21 B. Riley
- B. Riley calls Agenus the next Seagen, reiterates $8 target
- 04/12/21 Argus
- AstraZeneca downgraded to Hold from Buy at Argus
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
- 04/15/21 Credit Suisse
- Boeing price target raised to $233 from $193 at Credit Suisse
- 04/14/21 JPMorgan
- Boeing price target raised to $260 from $230 at JPMorgan
- 04/09/21 Baird
- Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
- 03/29/21 Goldman Sachs
- Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
LSCC Lattice Semiconductor - 02/17/21 Craig-Hallum
- Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
- 02/17/21 KeyBanc
- Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
- 02/17/21 Cowen
- Lattice Semiconductor price target raised to $56 from $48 at Cowen
- 02/17/21 Susquehanna
- Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
- $167.43 /
+13.57 (+8.82%) - 04/15/21 Citi
- Citi opens '30-day negative catalyst watch' on Axalta, PPG
- 04/07/21 Wells Fargo
- PPG price target raised to $173 from $165 at Wells Fargo
- 03/15/21 Credit Suisse
- PPG assumed with a Neutral at Credit Suisse
- 01/26/21 BofA
- PPG upgraded to Buy from Neutral at BofA
- 04/16/21 B. Riley
- Alcoa price target raised to $36 from $20 at B. Riley
- 04/16/21 BMO Capital
- Alcoa price target raised to $38 from $36 at BMO Capital
- 03/24/21 Morgan Stanley
- Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
- 04/16/21
- Fly Intel: Top five analyst initiations
- 04/16/21 Goldman Sachs
- Editas Medicine initiated with a Sell at Goldman Sachs
- 03/22/21 Credit Suisse
- Editas Medicine initiated with an Outperform at Credit Suisse
- 03/17/21 Guggenheim
- Editas Medicine assumed with a Neutral at Guggenheim
- $134.31 /
-14.09 (-9.49%) - 04/16/21
- Fly Intel: Top five analyst downgrades
- 04/16/21 KeyBanc
- Splunk downgraded to Sector Weight from Overweight at KeyBanc
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- $170.77 /
+10.95 (+6.85%) - 04/15/21 Piper Sandler
- Moderna price target raised to $234 from $208 at Piper Sandler
- 04/13/21 Piper Sandler
- Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
- 04/07/21 Jefferies
- Catalent pact with Moderna removes potential overhang, says Jefferies
- 04/09/21
- Pfizer to host conference call
- 04/06/21 RBC Capital
- Pfizer transferred with a Sector Perform at RBC Capital
- 04/16/21
- State Street reports Q1 ex-items EPS $1.47, consensus $1.35
- 01/19/21
- State Street reports Q4 EPS $1.39, consensus $1.56
- $134.31 /
-14.09 (-9.49%) - 03/03/21
- Splunk sees Q1 revenue $480M-$500M, consensus $507.29M
- 03/03/21
- Splunk reports Q4 EPS (86c) vs (15c) last year
- 03/03/21
- Notable companies reporting after market close
- 12/02/20
- Splunk withdrawing FY23 ARR and operating cash flow targets
- $167.43 /
+13.57 (+8.82%) - 04/16/21
- PPG sees Q2 adjusted EPS $2.15-$2.20, consensus $2.10
- 04/15/21
- PPG reports Q1 EPS $1.88, consensus $1.56
- 04/15/21
- Notable companies reporting after market close
- 01/22/21
- PPG sees Q1 adjusted EPS $1.55-$1.61, consensus $1.89
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19
- 02/02/21
- Pfizer reports Q4 adjusted EPS 42c, consensus 48c
- 02/01/21
- Notable companies reporting before tomorrow's open
- 04/16/21
- Morgan Stanley reports Q1 EPS $2.19, consensus $1.70
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/14/21
- Fly Intel: What to watch in next round of big bank earnings reports
- $170.77 /
+10.95 (+6.85%) - 02/25/21
- Moderna reports Q4 EPS (69c), consensus (35c)
- 02/24/21
- Notable companies reporting before tomorrow's open
- 10/29/20
- Moderna reports Q3 EPS (59c), consensus (43c)
LSCC Lattice Semiconductor - 02/16/21
- Lattice Semiconductor sees Q1 revenue $106M-$114M, consensus $103.4M
- 02/16/21
- Lattice Semiconductor reports Q4 EPS 19c, consensus 17c
- 02/16/21
- Notable companies reporting after market close
- 10/27/20
- Lattice Semiconductor sees Q4 revenue $99M-$107M, consensus $101.24M
- 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 02/25/21
- Editas Medicine reports Q4 EPS ($1.00), consensus (74c)
- 11/05/20
- Editas Medicine reports Q3 EPS 12c, consensus (64c)
- 04/16/21
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 04/16/21
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 04/15/21
- Citi reports Q1 EPS $3.62, consensus $2.60
- 04/14/21
- Notable companies reporting before tomorrow's open
- 04/16/21
- BNY Mellon reports Q1 EPS 97c, consensus 87c
- 01/20/21
- BNY Mellon reports Q4 ex-items EPS 96c, consensus 91c
- 01/27/21
- Boeing reports Q4 core EPS ($15.25), consensus ($1.80)
- 01/26/21
- Notable companies reporting before tomorrow's open
- 10/28/20
- Boeing reports Q3 core EPS ($1.39), consensus ($2.32)
- 04/07/21
- EMA says benefits of AstraZeneca Covid vaccine outweigh side effects
- 02/11/21
- AstraZeneca sees FY21 core EPS $4.75-$5.00
- 02/11/21
- AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B
- 11/05/20
- AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 10/29/20
- Alexion raises 2020 non-GAAP EPS view to $11.70-$12.00 from $10.65-$10.95
- 10/29/20
- Alexion reports Q3 non-GAAP EPS $3.24, consensus $2.60
- 04/15/21
- Alcoa reports Q1 adjusted EPS 79c, consensus 46c
- 01/20/21
- Alcoa reports Q4 adjusted EPS 26c, consensus 11c
- 01/20/21
- Notable companies reporting after market close
|
|
On The Fly
| ShowHide Related Items >><< - 04/16/21
- State Street raises FY fee revenue view to up 2.5%-4%
- 04/16/21
- State Street sees NII $460M-$465M per quarter from here in 2021
- 04/16/21
- State Street sees Q2 expenses up around 2.5% y/y
- 04/16/21
- State Street sees fee revenues up 2%-3% y/y in Q2
- 04/16/21
- Splunk slides 7% after Chief Technology Officer resigns
- 04/14/21
- Carahsoft agreement for Splunk solutions designated CETA by DoD
- 04/13/21
- Splunk CEO sells 15.5K shares of common stock
- 04/05/21
- Splunk appoints Teresa Carlson as Chief Growth Officer
- $170.26 /
+16.4 (+10.66%) - 04/16/21
- PPG rises 10.3%
- 04/16/21
- PPG rises 11.1%
- 04/16/21
- PPG rises 10.4%
- 04/16/21
- PPG says expects to complete the acquisitions of Tikkurila, Worwag during Q2
- 04/16/21
- Morgan Stanley says 'very active' in recruiting advisors
- 04/16/21
- Morgan Stanley expects net interest income to grow from current levels
- 04/16/21
- Morgan Stanley says investment banking pipelines 'healthy across products'
- 04/16/21
- Morgan Stanley says Archegos exit 'money well spent'
LSCC Lattice Semiconductor - 04/15/21
- Lattice Semiconductor to replace PTC in S&P 400 at open on 4/20
- 02/23/21
- Lattice Semiconductor announces $60M stock buyback
- 12/15/20
- Everspin Technologies CEO Kevin Conley to step down
- 12/08/20
- Lattice Semiconductor launches 2nd generation security solution FPGAA
- 04/15/21
- Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors
- 04/15/21
- Merck to discontinue development of MRK-7110 in COVID-19 treatment
- 04/14/21
- EMA says 'expediting' evaluation of Johnson & Johnson COVID-19 vaccine
- 04/13/21
- J&J pauses vaccinations in all COVID-19 vaccine clinical trials
- 02/08/21
- Editas Medicine appoints James Mullen as CEO
- 01/11/21
- Editas Medicine Chief Scientific Officer Charles Albright, Ph.D to step down
- 01/11/21
- Editas Medicine says FDA clears initiation of EDIT-301 clinical trial
- 12/21/20
- Editas leads gene editing stocks higher with 46% rally to $95.42
- 04/16/21
- Citizens Financial CEO says 'confident' in outlook for balance of year
- 04/16/21
- Citizens Financial reports Q1 net interest margin 2.76% vs. 3.10% a year ago
- 01/27/21
- Citizens announces consumer financing partnership with BJ's Wholesale Club
- 01/20/21
- Citizens Financial sees high single digit decrease in FY21 NIM
- 04/14/21
- BNY Mellon chosen as transfer agent of Charles Schwab Investment Management
- 03/22/21
- AFL-CIO teams with Wilmington Trust, BNY Mellon on retirement plan options
- 02/16/21
- Amundi US appoints BNY Mellon as fund service provider
- 02/11/21
- BNY Mellon announces formation of new digital assets unit
- 04/14/21
- Denmark to continue vaccine rollout without AstraZeneca COVID-19 vaccine
- 04/14/21
- AstraZeneca's Tagrisso approved in China in early lung cancer
- 04/12/21
- AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint
- 04/16/21
- AstraZeneca reports U.S. clearance of proposed acquisition of Alexion
- 03/26/21
- Arcutis Biotherapeutics announces updates to its executive team
- 03/16/21
- AstraZeneca withdraws FTC notification on Alexion deal, plans to refile
- 02/22/21
- Arcturus Therapeutics acquires exclusive license from Alexion
- 04/16/21
- Alcoa rises 8.1%
- 04/15/21
- Alcoa jumps 2% to $33.50 after Q1 earnings beat
- 04/15/21
- Alcoa reports Q1 adjusted EBITDA $521M, up 44% from Q4
- 04/15/21
- Alcoa expecting strong 2021 on continued economic recovery
- 04/09/21 JMP Securities
- Goldman Sachs price target raised to $400 from $338 at JMP Securities
- 04/07/21 Barclays
- Morgan Stanley price target raised to $98 from $95 at Barclays
- 04/01/21 Deutsche Bank
- Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
- 04/01/21 UBS
- Morgan Stanley price target raised to $92 from $84 at UBS
- 04/09/21 Deutsche Bank
- BNY Mellon price target raised to $54 from $50 at Deutsche Bank
- 04/07/21 Barclays
- BNY Mellon price target raised to $57 from $55 at Barclays
- 03/26/21 JPMorgan
- JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
- 03/24/21
- Fly Intel: Top five analyst upgrades
- 04/09/21 Jefferies
- Citizens Financial price target raised to $47 from $42 at Jefferies
- 04/07/21 Barclays
- Citizens Financial price target raised to $54 from $49 at Barclays
- 04/01/21 Deutsche Bank
- Citizens Financial price target raised to $50 from $44 at Deutsche Bank
- 03/30/21 Stephens
- Citizens Financial price target raised to $54 from $45 at Stephens
- 04/09/21 Deutsche Bank
- State Street price target raised to $100 from $97 at Deutsche Bank
- 04/07/21 Barclays
- State Street price target raised to $104 from $99 at Barclays
- 04/01/21 Wells Fargo
- State Street price target raised to $90 from $83 at Wells Fargo
- 04/01/21 Morgan Stanley
- State Street price target raised to $103 from $102 at Morgan Stanley
- 03/23/21
- Fly Intel: Top five analyst downgrades
- 03/23/21 SVB Leerink
- SVB Leerink moving to sidelines on Alexion, five others on industry concerns
- 03/23/21 SVB Leerink
- Alexion downgraded to Market Perform from Outperform at SVB Leerink
- 02/04/21 Piper Sandler
- Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/12/21
- Fly Intel: Top five analyst downgrades
- 04/12/21 B. Riley
- B. Riley calls Agenus the next Seagen, reiterates $8 target
- 04/12/21 Argus
- AstraZeneca downgraded to Hold from Buy at Argus
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/13/21 JPMorgan
- Vaccine pause 'incremental negative' for J&J, says JPMorgan
LSCC Lattice Semiconductor - 02/17/21 Craig-Hallum
- Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
- 02/17/21 KeyBanc
- Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
- 02/17/21 Cowen
- Lattice Semiconductor price target raised to $56 from $48 at Cowen
- 02/17/21 Susquehanna
- Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
- $170.26 /
+16.4 (+10.66%) - 04/15/21 Citi
- Citi opens '30-day negative catalyst watch' on Axalta, PPG
- 04/07/21 Wells Fargo
- PPG price target raised to $173 from $165 at Wells Fargo
- 03/15/21 Credit Suisse
- PPG assumed with a Neutral at Credit Suisse
- 01/26/21 BofA
- PPG upgraded to Buy from Neutral at BofA
- 04/16/21 B. Riley
- Alcoa price target raised to $36 from $20 at B. Riley
- 04/16/21 BMO Capital
- Alcoa price target raised to $38 from $36 at BMO Capital
- 03/24/21 Morgan Stanley
- Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
- 04/16/21
- Fly Intel: Top five analyst initiations
- 04/16/21 Goldman Sachs
- Editas Medicine initiated with a Sell at Goldman Sachs
- 03/22/21 Credit Suisse
- Editas Medicine initiated with an Outperform at Credit Suisse
- 03/17/21 Guggenheim
- Editas Medicine assumed with a Neutral at Guggenheim
- 04/16/21
- Fly Intel: Top five analyst downgrades
- 04/16/21 KeyBanc
- Splunk downgraded to Sector Weight from Overweight at KeyBanc
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- 04/08/21 BofA
- Splunk reinstated with a Buy at BofA
- 04/16/21
- State Street reports Q1 ex-items EPS $1.47, consensus $1.35
- 01/19/21
- State Street reports Q4 EPS $1.39, consensus $1.56
- 03/03/21
- Splunk sees Q1 revenue $480M-$500M, consensus $507.29M
- 03/03/21
- Splunk reports Q4 EPS (86c) vs (15c) last year
- 03/03/21
- Notable companies reporting after market close
- 12/02/20
- Splunk withdrawing FY23 ARR and operating cash flow targets
- $170.26 /
+16.4 (+10.66%) - 04/16/21
- PPG sees Q2 adjusted EPS $2.15-$2.20, consensus $2.10
- 04/15/21
- PPG reports Q1 EPS $1.88, consensus $1.56
- 04/15/21
- Notable companies reporting after market close
- 01/22/21
- PPG sees Q1 adjusted EPS $1.55-$1.61, consensus $1.89
- 04/16/21
- Morgan Stanley reports Q1 EPS $2.19, consensus $1.70
- 04/15/21
- Notable companies reporting before tomorrow's open
- 04/14/21
- Fly Intel: What to watch in next round of big bank earnings reports
LSCC Lattice Semiconductor - 02/16/21
- Lattice Semiconductor sees Q1 revenue $106M-$114M, consensus $103.4M
- 02/16/21
- Lattice Semiconductor reports Q4 EPS 19c, consensus 17c
- 02/16/21
- Notable companies reporting after market close
- 10/27/20
- Lattice Semiconductor sees Q4 revenue $99M-$107M, consensus $101.24M
- 01/26/21
- Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45
- 01/26/21
- Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82
- 01/25/21
- Notable companies reporting before tomorrow's open
- 02/25/21
- Editas Medicine reports Q4 EPS ($1.00), consensus (74c)
- 11/05/20
- Editas Medicine reports Q3 EPS 12c, consensus (64c)
- 04/16/21
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 04/16/21
- Citizens Financial reports Q1 underlying EPS $1.41, consensus 97c
- 04/16/21
- BNY Mellon reports Q1 EPS 97c, consensus 87c
- 01/20/21
- BNY Mellon reports Q4 ex-items EPS 96c, consensus 91c
- 04/07/21
- EMA says benefits of AstraZeneca Covid vaccine outweigh side effects
- 02/11/21
- AstraZeneca sees FY21 core EPS $4.75-$5.00
- 02/11/21
- AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B
- 11/05/20
- AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 02/04/21
- Alexion reports Q4 EPS $2.96, consensus $2.56
- 10/29/20
- Alexion raises 2020 non-GAAP EPS view to $11.70-$12.00 from $10.65-$10.95
- 10/29/20
- Alexion reports Q3 non-GAAP EPS $3.24, consensus $2.60
- 04/15/21
- Alcoa reports Q1 adjusted EPS 79c, consensus 46c
- 01/20/21
- Alcoa reports Q4 adjusted EPS 26c, consensus 11c
- 01/20/21
- Notable companies reporting after market close
|